Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged(TSE:ABT)
CA$18.89+0.21 (+1.12%)
TSE:ABT
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged financials statements
CA$18.89
At close:+0.21 (+1.12%)
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (ABT) Income Statement
3 Followers
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Income Statement
Last quarter (Q3 2020), Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's total revenue was $28.50M, an increase of 11.08% from the same quarter last year. In Q3, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's net income was $2.60M. See Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 20 | Jun 19 | Jun 18 |
|---|---|---|---|
| $ 104.67M | $ 98.91M | $ 93.62M | |
| $ 92.04M | $ 85.93M | $ 79.26M | |
| $ 76.78M | $ 75.03M | $ 76.38M | |
| Depreciation and Amortization | $ 5.32M | $ 3.42M | $ 12.40M |
| $ 21.18M | $ 14.53M | $ 15.26M | |
| $ 15.27M | $ 10.90M | $ 2.88M | |
| $ -24.50K | $ 209.09K | $ -18.52K | |
| $ 15.24M | $ 11.11M | $ 2.86M | |
| $ 10.63M | $ 7.58M | $ 3.11M | |
| Per Share Metrics | |||
| Basic EPS | $ 0.24 | $ 0.18 | $ 0.08 |
| Diluted EPS | $ 0.24 | $ 0.18 | $ 0.08 |
| Weighted Average Shares Outstanding | 44.75M | 42.11M | 40.03M |
| Weighted Average Shares Outstanding (Diluted) | 44.75M | 42.11M | 40.03M |
Currency in USD

